What supplements are recommended to support heart health?

Heart Health Supplements: Evidence-Based Recommendations

Primary Recommendation

For the general adult population, do not routinely prescribe or recommend multivitamins, antioxidant supplements (vitamins A, C, E), or most other dietary supplements for cardiovascular disease prevention, as the evidence shows no benefit and potential harm. 1, 2

---

What NOT to Recommend

Multivitamins and Antioxidants

• The USPSTF concludes with insufficient evidence (Grade I) to recommend multivitamins for cardiovascular disease or cancer prevention in healthy adults. 1, 2
• Antioxidant vitamin supplements (vitamins A, C, E) or selenium are not recommended for CVD prevention, as clinical trials have not confirmed benefits seen in observational studies. 1
• Beta-carotene supplements are explicitly contraindicated in smokers and those with asbestos exposure due to increased lung cancer risk and all-cause mortality. 1
• High-dose vitamin E supplements may increase risk of heart failure and total mortality. 1

B Vitamins and Folate

• Folate and B vitamin supplements (B6, B12) are not recommended for CVD risk reduction in the general population, as homocysteine-lowering trials have been disappointing. 1

Soy Protein and Isoflavones

• Soy protein supplements show minimal cardiovascular benefit, with recent studies failing to confirm earlier favorable effects on LDL cholesterol. 1
• Any modest LDL reduction requires consuming more than half of daily protein intake as soy, primarily in hypercholesterolemic individuals. 1

---

What TO Recommend: Omega-3 Fatty Acids

General Population

• Recommend consuming fatty fish at least twice weekly rather than supplements for general cardiovascular health. 3
• If fish consumption is not feasible, plant-based alpha-linolenic acid (ALA) sources include walnuts, flaxseeds, and canola oil at 1.5-3 grams daily. 3

Documented Coronary Heart Disease (Secondary Prevention)

• Prescribe 850-1,000 mg EPA+DHA daily for patients with established CHD, which reduces cardiovascular events by 9% for MI and 7% for total coronary disease. 3
• This dose carries no identified bleeding risks and is supported by the GISSI-Prevenzione trial showing 45% reduction in sudden death. 3

Hypertriglyceridemia

• For triglycerides 200-499 mg/dL: prescribe 2-4 grams EPA+DHA daily under physician supervision for 30% or greater triglyceride reduction. 3
• For severe hypertriglyceridemia (≥500 mg/dL): prescribe 4 grams EPA+DHA daily under physician supervision, reducing triglycerides by approximately 45%. 3
• Critical caveat: Omega-3s typically increase LDL cholesterol by 5-10%, especially in patients with very high baseline triglycerides, requiring concurrent statin therapy and LDL monitoring. 4

Safety Thresholds for Omega-3s

• Doses up to 5 grams daily are safe without increased bleeding risk, even with concurrent antiplatelet or anticoagulant therapy. 3
• However, doses >1 gram daily increase atrial fibrillation risk by 25%, with highest risk at 4 grams daily or more (REDUCE-IT trial: 3.1% vs 2.1% hospitalization for AFib). 3
• Patients taking >3 grams daily require physician supervision with initial bimonthly bleeding time checks, then monthly monitoring. 3

---

Special Populations Requiring Supplementation

Women of Childbearing Age

• Prescribe daily folic acid supplementation for women planning pregnancy or who may become pregnant to prevent neural tube defects. 1, 2

Diabetic Patients on Metformin

• Conduct periodic vitamin B12 testing and supplementation for patients on long-term metformin therapy. 2

Older Adults at Risk for Falls

• Prescribe vitamin D supplements for fall prevention in this specific population. 1

---

Clinical Approach Algorithm

Step 1: Assess for documented nutritional deficiencies requiring targeted replacement (not routine supplementation). 2

Step 2: For cardiovascular health, prioritize dietary counseling over supplements:

• Emphasize diets rich in fruits, vegetables, whole grains, and fatty fish. 1, 2
• The 2010 Dietary Guidelines recommend nutrients come primarily from foods, not supplements. 1

Step 3: For patients with established CHD, prescribe omega-3s at 850-1,000 mg EPA+DHA daily. 3

Step 4: For hypertriglyceridemia, prescribe omega-3s at 2-4 grams daily with LDL monitoring and statin co-therapy. 3, 4

Step 5: If patients insist on taking multivitamins despite insufficient evidence:

• Provide harm-reduction counseling. 2
• Advise adherence to Dietary Reference Intakes dosages to avoid toxicity. 1, 2
• Emphasize supplements do not replace healthy diet or proper medication adherence. 2
• Warn about lack of FDA regulation and variable product quality. 5, 6, 7

---

Critical Pitfalls to Avoid

Regulatory Issues

• Dietary supplements lack FDA pre-market approval and quality control, leading to variable ingredient content, contamination risks, and presence of undeclared pharmaceuticals. 5, 6, 7
• Manufacturers are exempt from conducting clinical trials by classifying products as supplements rather than drugs. 7

Patient Misconceptions

• Many patients assume supplements will treat disease, improve health, or delay aging without evidence. 7
• Patients may delay appropriate medical treatment by self-treating with supplements. 8, 7

Drug-Supplement Interactions

• Monitor for potential interactions, particularly with anticoagulants, though omega-3s up to 5 grams daily do not increase bleeding risk. 3, 8
• Patients on ibrutinib should completely avoid fish oil supplements due to epistaxis risk. 3

Dosing Errors

• Vitamins A and D have known harms at doses exceeding tolerable upper intake levels. 1
• Fat-soluble vitamins accumulate, requiring consideration of lifetime high-dose effects. 1

---

Evidence Quality Summary

Strongest evidence (moderate certainty):

• Beta-carotene causes harm in smokers. 1
• Vitamin E provides no benefit for CVD/cancer. 1
• Omega-3s reduce cardiovascular events in CHD patients. 3

Insufficient evidence (Grade I):

• Multivitamins for CVD/cancer prevention. 1, 2
• Individual vitamins A, C, E for CVD/cancer prevention. 1
• Antioxidant combinations for CVD/cancer prevention. 1

The consistent message across all major guidelines (AHA 2006, USPSTF 2014, AAFP) is that dietary modification provides more consistent cardiovascular benefits than supplementation. 1, 2